mCRC: Trifluridin/Tipiracil in Europa zugelassen
Crossref DOI link: https://doi.org/10.1007/s15015-016-2659-y
Published Online: 2016-06-14
Published Print: 2016-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
red,
